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.2013.04Abstract Background: Risk factors of childhood obesity include; energy intake, positive family
history and lifestyle. Obesity is associated with numerous co-morbidities such as cardiovascular dis-
eases and type 2 diabetes.
Objective: To study serum lipid proﬁle and evaluate the left ventricular systolic and global func-
tions in obese children, and deﬁne the preclinical effects of obesity, per se, on myocardial function
and cardiovascular system.
Patients and methods: This is a 9-Month prospective controlled study, done in Pediatrics Depart-
ment Tanta University Hospital. 30 patients were included (24 males, six females); aged 6–15 years
with BMI > age and sex speciﬁc cut off points. Exclusion criteria included organic causes of obes-
ity, hormonal medications, corticosteroids, hypertension and diabetes mellitus. Twenty healthy chil-
dren age and sex matched were set as the control group. Studied children were subjected to:
anthropometric measurements: weight, height and BMI. Echocardiographic evaluation: LVEF,VD, cardiovascular diseases;
contraction; IVRT, relaxation
esterol; LMPI, left ventricular
ft ventricular; LVEDD, left
EF, left ventricular ejection
ystolic dimension; LVFS, left
left ventricular hypertrophy;
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16 A.M. Zoair et al.LVFS, LVEDD, predicted LVEDD, % LVEDD, LVM, LVMI and LMPI. Lipid proﬁle assessment:
included serum TCh, LDL, TCh/HDL ratio and TG.
Results: There was highly signiﬁcant increase in body weight, serum TCh, LVEDD, LVM and
LVMI; signiﬁcant increase in BMI, LDL, HDL, serum TG, TCh/HDL-cholesterol ratio, %
LVEDD, predicted LVEDD and LMPI of obese as compared to controls. There was no signiﬁcant
difference between the two studied groups as regards height, LVEF and LVFS. There was signiﬁ-
cant decrease in HDL in obese patients as compared to the control group.
Conclusions: Complete evaluation of cardiac function in obese children should include echocardi-
ography along with LMPI (useful marker for early detection of LV global dysfunction), in combi-
nation with measurement of lipid proﬁle.
ª 2013 Production and hosting by Elsevier B.V. on behalf of The Egyptian Paediatric Association.1. Introduction
Individuals whose body mass index (BMI) exceeds the age-
gender-speciﬁc 95th percentile are obese, while those whose
BMI is between 85th and 95th percentiles are overweight and
are at an increased risk for obesity and related co-morbidities.1
Worldwide, over 22 million children under the age of ﬁve
are severely overweight, as are 155 million children of school
age. This implies that one in 10 children worldwide is over-
weight.2 In Egypt, childhood obesity has been on the rise over
the past 10 years. The national study on obesity revealed that,
among teenagers obesity ranged at around 10% among girls
and 7% among boys. In children, aged 6–11, obesity among
girls was 6.5% and 4.5% among boys. From age 2–6, obesity
reached 3% among girls and 1.7% among boys.3
The potential risk factors include; frequency of obesity
among the family, eating habits, energy intake and the family’s
lifestyle.4
The prevalence of overweight and obesity has signiﬁcantly
increased in the pediatric population, warning against a world
epidemic. This is alarming because metabolic changes and the
consequences of obesity, formerly observed only in the adults,
are now observed in younger individuals.5
It is important to distinguish between simple obesity and
the rarer situation of secondary obesity owing to genetic
disorders, endocrine diseases, central nervous system lesions,
or iatrogenic causes. Detailed medical history, physical exam-
ination, and laboratory tests are helpful.6
Health consequences fall into two broad categories: those
attributable to the effects of increased fat mass (such as osteo-
arthritis, obstructive sleep apnea, social stigmatization), and
those due to the increased number of fat cells (diabetes, cancer,
cardiovascular disease, non-alcoholic fatty liver disease).7 In-
creases in body fat alter the body’s response to insulin, poten-
tially leading to insulin resistance. Increased fat also creates a
pro-inﬂammatory state8 and a prothrombotic state.9
Obesity is associated with numerous co-morbidities such as
cardiovascular diseases (CVD), type 2 diabetes, hypertension,
dyslipidemias, certain cancers, osteoarthritis, proteinuria, sleep
apnea; sleep disordered breathing, depression and anxiety.
Furthermore, childhood obesity is associated with endothelial
dysfunction and is an independent predictor of coronary artery
disease and premature death in adults.10
Obese adolescents exhibit changes in the left ventricular
(LV) mass related to increase in cardiac workload.11 Even with
normal ventricular mass, overweight children exhibit subtlechanges in LV systolic and diastolic function that may have
implications for their future cardiovascular health.12
The aim of this study was to evaluate the left ventricular
systolic and global functions in children with obesity, to study
serum lipid proﬁle in obese children, and to deﬁne the preclin-
ical effects of obesity, per se, on myocardial function and car-
diovascular system.2. Patients and methods
2.1. Patients
Thirty obese children of both sexes were enrolled in this study
aged 6–15 years, (24 males and six females). They were chosen
after anthropometric assessment as their BMI > age and sex
speciﬁc cut off points13 from those attending the outpatient
clinic or pediatric endocrinology and metabolism******.
This study was done in Clinic of Tanta University hospital,
in the period from January 2010 to September 2010. Any Ob-
ese child who had any known organic cause of obesity, re-
ceived any hormonal medication or corticosteroids, had
hypertension, diabetes mellitus, endocrine disorder, hereditary
or genetic syndrome associated with obesity such as Prader–
Willi syndrome, obstructive sleep apnea or any chronic disease
was excluded due to the inﬂuence of possible co-morbidities of
obesity.
Twenty healthy children matched for age and sex, chosen
from schools were set as a control group. Studied cases and
their parents were instructed about the study and informed
consent was obtained.
2.2. Methods
All studied children were subjected to the following:
(I) History taking including: Time of beginning of increased
body weight, associated increased appetite, types of
foods, daily activities, past history of any medical prob-
lems or any drugs taken, any similar condition in the
family, any cardiovascular problems in the patient or
family members, any chest complaint like tachypnea or
dyspnea, if the child feels drowsiness, hypoactivity or
sleepiness.
(II) Clinical examination including:
Anthropometric measurements
Lipid proﬁle and some cardiac functions in children with obesity 17(a) Body weight: with the patient bare-feet, and jackets
and pullovers taken off. Using spring scale, placed
on a hard, leveled uncarpeted ﬂoor. Weight was mea-
sured to the nearest half kilogram, expressed as % of
ideal body weight for age (50th percentile weight for
age).
(b) Body height: measured standing bare-feet, head was
looking directly forward and the patient stretching
his/her fullest height. Using a standard tape ﬁxed verti-
cally on the wall, the patients were instructed to adhere
tightly to the wall at the shoulders, buttocks, back of
knees and heel. Height was measured in centimeters
to the nearest half centimeter. It was calculated as per-
cent from the ideal height (50th percentile height for
age).
(c) Body mass index (BMI): {weight in kilograms divided by
square of the height in meters; kg/m2} is compared with
age and reference standards.14 Obese children had BMI
P95th percentile.
(III) Investigations:
(A) Echocardiographic evaluation: using a Vivid 7 ultra-
sound machine (GE Medical System, Horten, Norway with a
3.5-MHz multifrequency transducer). Echocardiographic
(ECHO) examination of Obese and controls included the fol-
lowing parameters:
(a) LV systolic function15: (1) Left ventricular ejection
fraction (LVEF %). Where LVEF (%) = {[left ventric-
ular end  diastolic dimension (LVEDD)3  left ven-
tricular end  systolic dimension (LVESD)3]/
(LVEDD)3} · 100. (2) Left ventricular fractional short-
ening (LVFS %). Where LVFS (%) = {[LVEDD  L-
VESD]/LVEDD} · 100. [LVEDD in (mm) and
LVESD in (mm)].
(b) LV dimensions: (using M-mode echocardiography). (3)
LVEDD.15 (4) The predicted LVEDD: was calculated
using the Henry equation16:Table 1 Demographic data of the studied groups.
Control (n= 20) Obese (n= 30)
Age (years)
Range 6–13 6–15
Mean 9.60 10.56
±SD 2.56 2.82
t test 1.225
p value 0.325
Sex
Male N (%) 14 (70%) 24 (80%)
Female N (%) 6 (30%) 6 (20%)
Chi-square v2 = 0.625
p= 0.428Predicted LVEDD ¼ ½45:3 body surface area ðm2Þ  ½0:03
 age ðyearsÞ  7:2
where: body surface area (m2) = (weight · 4) ± 7 weight +
90
(5) % LVEDD: the ratio of left ventricular end-diastolic
dimension to predicted LVEDD expressed in percentage
(% LVEDD) was calculated using the following formula17:
%LVEDD¼½ðMeasuredLVEDDÞ=ðPredictedLVEDDÞ100
(6) Left ventricular mass (LVM): was calculated using the
following formula17:
LVM ðgÞ ¼ 0:8 ½1:04ðLVEDD IVSD LVPWDÞ3
 LVEDD3  0:6
where, IVSD is inter-ventricular septum dimension (cm) and
LVPWD is left ventricular posterior wall dimension (cm).
(7) Left ventricular mass index (LVMI): was calculated
using the following formula:LVMI ¼ LVM=height ðmÞ2:7
It was used to evaluate left ventricular hypertrophy (LVH)
adjusted to body size.18(c) LV global function assessment: by
Doppler-derived Left ventricular Myocardial Performance In-
dex (LMPI)19:
Mitral inﬂow and left ventricular outﬂow velocity–time
intervals were used to measure Doppler time intervals: isovol-
umetric contraction (IVCT), relaxation time (IVRT) and ejec-
tion time (ET). The interval ‘‘a’’ from the cessation to the
onset of mitral inﬂow was equal to the sum of IVCT, ET,
and IVRT (a= IVCT+ ET+ IVRT). Left ventricular ET
‘‘b’’ was the duration of left ventricular velocity proﬁle. Thus,
the sum of IVCT and IVRT was obtained by subtracting ‘‘b’’
from ‘‘a’’. The MPI was calculated as: (a  b)/b
[MPI = (a  b)/b].
The normal range for LMPI in children (3–18 years) is
0.33 ± 0.05.
(B) Lipid proﬁle assessment:
5 ml morning blood samples (without anticoagulant) were
collected from all children after a minimum of 12-h fasting,
and with the routine procedure (determination of total choles-
terol (TCh), high-density lipoprotein cholesterol (HDL), low
density lipoprotein cholesterol (LDL), and TG was performed
by colorimetric enzyme method on a RA-50 Chemistry Ana-
lyser spectrophotometer (Bayer), using LABTEST reagents),
and using an automated instrument, these investigations for li-
pid proﬁle assessment were done20:
(1) Serum TCh
(2) HDL-cholesterol.
(3) LDL-cholesterol from the equation:
(4) LDL= TCh  (HDL + TG/5)20
(5) TCh/HDL-cholesterol ratio.
(6) Serum TG.3. Results
Table 1 shows that there was no signiﬁcant difference be-
tween control (9.60 ± 2.56) and obese (10.56 ± 2.82) groups
regarding age (years), (p> 0.05). Also, there was no signiﬁ-
cant difference between control (14 males and six females)
and obese (24 males and six females) groups regarding sex
(p> 0.05).
Table 2 Anthropometric measurements of the two studied
groups.
Control Obese
Regarding weight (kg)
Range 20–48 32–98
Mean 39.92 59.48
±SD 11.26 21.69
t test 3.703
p value 0.001*
Regarding height (cm)
Range 116–166 96–159
Mean 139.40 139.63
±SD 16.10 17.43
t test 0.438
p value 0.752
Regarding BMI (kg/m2)
Range 14.7–22.8 28.7–39.8
Mean 20.15 33.02
±SD 2.32 3.03
t test 16.523
p value 0.009*
* = signiﬁcant.
Table 3 Lipid proﬁle of the two studied groups.
Control Obese
Control Obese
Regarding TCh (mg/dl)
Range 120–175 107–395
Mean 146.10 197.80
±SD 16.14 24.63
t test 10.325
p value 0.001*
Regarding LDL (mg/dl)
Range 66–86.4 45–297.4
Mean 76.88 110.82
±SD 11.36 59.33
t test 4.325
p value 0.009*
Regarding HDL (mg/dl)
Range 48–75 21–128
Mean 59.63 56.14
±SD 13.36 14.25
t test 2.996
p value 0.044*
Regarding TG (mg/dl)
Range 80–120 36–200
Mean 101.10 136.56
±SD 12.30 47.12
t test 3.539
p value 0.003*
Regarding TCh/HDL ratio
Range 1.7–3.3 1.6–9.6
Mean 2.648 4.586
±SD 0.543 2.95
t test 2.412
p value 0.035*
* = signiﬁcant.
Table 4 Echocardiographic evaluation of the two studied
groups.
Control Obese
Regarding LVEF (%)
Range 57.5–75.47 54.5–85.3
Mean 67.82 71.29
±SD 5.31 7.27
t test 1.325
p value 0.091
Regarding LVFS (%)
Range 30.3–43.7 30–47.4
Mean 37.53 40.91
±SD 5.33 6.30
t test 1.536
p value 0.079
Regarding LVEDD (%)
Range 43.5–94.9 63–111.9
Mean 77.73 90.79
±SD 14.15 11.77
t test 3.528
p value 0.004*
* = signiﬁcant.
18 A.M. Zoair et al.3.1. Anthropometric measurements
Table 2 shows that the control had mean weight of
39.92 ± 11.26 kg while obese had 59.48 ± 21.69 kg. There
was highly signiﬁcant increase of body weight of obese as com-
pared to control (p 6 0.001). Also, it shows that the control
had a mean height of 139.40 ± 16.10 and obese children had
139.63 ± 17.43 cm. there was no signiﬁcant difference between
the two studied groups as regards height (p> 0.05). In addi-
tion, the control had mean BMI of 20.15 ± 2.32 and obese
33.02 ± 3.03 kg/m2. There was signiﬁcant increase of BMI in
obese as compared to the control group (p< 0.05).
3.2. Lipid proﬁle
Table 3 shows that the control had mean TCh level of
146.10 ± 16.14 and obese 197.80 ± 24.63 mg/dl. There was
highly signiﬁcant increase of serum TCh in obese children as
compared to the control group (p 6 0.001). Also, it shows that
the control had mean LDL-cholesterol level of 76.88 ± 11.36
and obese 110.82 ± 59.33 mg/dl. There was signiﬁcant in-
crease in LDL-cholesterol levels in obese children as compared
to the control group (p< 0.05).
In addition, the control had a mean HDL-cholesterol level
of 59.63 ± 13.36 and obese 56.14 ± 14.25mg/dl. There was
signiﬁcant decrease in HDL-cholesterol levels in obese children
as compared to control group (p< 0.05).
Moreover, the controls had mean TG level of 101.10 ±
12.30 and obese 136.56 ± 47.12 mg/dl. There was signiﬁcant
increase of serum TG in obese children as compared to the
control group (p< 0.05).
Table 3 also shows that controls had mean cholesterol/
HDL ratio of 2.648 ± 0.543 and obese 4.586 ± 2.95. There
was a signiﬁcant increase of TCh/HDL-cholesterol ratio in ob-
ese children as compared to the control group (p< 0.05).
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Table 4 shows that the controls had mean LVEF of 67.82 ±
5.31 and obese 71.29 ± 7.27%. There was no signiﬁcant
difference between the two studied groups as regards ejection
fraction (p> 0.05).Table 5 Echocardiographic evaluation of the two studied
groups.
Control Obese
Regarding LVEDD (cm)
Range 1.8–4.1 3.1–4.9
Mean 3.30 4.11
±SD 0.647 0.535
t test 4.817
p value 0.001*
Regarding predicted LVEDD (cm)
Range 3.48–4.7 3.4–4.9
Mean 4.25 4.53
±SD 0.48 0.33
t test 2.431
p value 0.019*
* = signiﬁcant.
Table 6 Echocardiographic evaluation of the two studied
groups.
Control Obese
Control Obese
Regarding LVM (g)
Range 36.05–76.4 66.6–217
Mean 47.04 108.71
±SD 16.23 39.52
t test 6.938
p value 0.001*
Regarding LVMI (g)
Range 12.06–40.7 29.9–90.2
Mean 20.33 46.42
±SD 8.86 19.23
t test 5.325
p value 0.001*
* = signiﬁcant.
Table 7 Comparison between the two studied groups regard-
ing LMPI.
LMPI Control Obese
Range 0.28–0.38 0.40–2.1
Mean 0.330 0.681
±SD 0.051 0.571
t test 4.632
p value 0.009*
* = signiﬁcant.Also, it shows that the controls had mean LVFS of 37.53 ±
5.33 and obese 40.91 ± 6.30%. There was no signiﬁcant differ-
ence between the two studied groups as regards fractional
shortening (p> 0.05).
Additionally, it shows that the controls had mean %
LVEDD of 77.73 ± 14.15 and obese 90.79 ± 11.77%. There
was signiﬁcant increase of the % LVEDD in obese children
as compared to control group (p< 0.05).
Table 5 shows that the controls had mean LVEDD of
3.30 ± 0.647 and obese 4.11 ± 0.535 cm. There was highly sig-
niﬁcant increase of the LVEDD in obese children as compared
to the control group (p 6 0.001). Likewise, it shows that the
controls had mean predicted LVEDD of 4.25 ± 0.48 and ob-
ese 4.53 ± 0.33 cm. there was signiﬁcant increase of the pre-
dicted LVEDD in obese children as compared to the control
group (p< 0.05).
Table 6 shows that the controls had mean LVM of
47.04 ± 16.23 and obese 108.71 ± 39.52 g. There was highly
signiﬁcant increase of the LVM in obese as compared to the
control group (p 6 0.001).
Also, the controls had mean LVMI of 20.33 ± 8.86 and ob-
ese 46.42 ± 19.23. There was highly signiﬁcant increase of the
LVMI in obese as compared to the control group (p 6 0.001)
Table 7 shows that the controls had mean LMPI of
0.330 ± 0.051 and obese 0.681 ± 0.571. There was signiﬁcant
increase of the LMPI in obese children as compared to the
control group (p< 0.05).4. Discussion
The extent of the epidemic of childhood obesity is increasing
so that children are suffering chronic complications that were
once only seen in adults.21 The World Health Organization de-
scribes the ‘‘escalating global epidemic’’ of obesity as ‘‘one of
today’s most blatantly visible – yet most neglected – public
health problems’’.22
Our study was done on two groups of comparable age and
sex; obese children and control group of non-obese children.
As regards age, the study revealed no signiﬁcant difference be-
tween the two groups. A critical period for the development of
adult obesity is adolescence. Obesity that develops in or per-
sists into adolescence is not only the most difﬁcult to treat,
but is also associated with the greatest risk of serious
complications.23
Our study revealed that there was no signiﬁcant difference
between gender and obesity. There are contradictory results
about this item; Pyke,24 found no signiﬁcant difference be-
tween boys’ and girls’ obesity. However, LaFrance et al.25 sta-
ted that boys’ obesity was higher than girls’ obesity. But Raja’a
and Bin-Mohanna,26 reported that prevalence of overweight
and obesity was higher among females. These differences
may be due to the difference in localities, sample size, cultural
and/or socioeconomic causes.
The present study shows that the BMI was signiﬁcantly
higher in obese children as compared to non-obese children.
The use of WHO standards for BMI-for-age in 2006 provides
only a crude measure of body fatness, since it does not distin-
guish between weight associated with muscle and weight asso-
ciated with fat.27
Regarding lipid proﬁle, this study demonstrated that HDL
was signiﬁcantly lower in obese as compared to non-obese chil-
20 A.M. Zoair et al.dren. However, LDL, serum TG, serum TCh and TCh/HDL
ratio were signiﬁcantly higher in obese children as compared
to control.
This was in accordance with Freedman et al.28 and Reinhr
et al.29 who found that overweight is strongly related to con-
centrations of HDL-cholesterol and TG and weakly related
to concentrations of LDL-cholesterol; while Kim et al.30 found
that all types of lipids were signiﬁcantly associated with over-
weight and obesity. Also, Chinali et al.11 stated that obese ado-
lescents had signiﬁcantly higher total TG and lower high-
density lipoprotein.
Moreover, Lima et al.31 stated that Total and LDL-choles-
terol levels were higher in obese than normal weight children.
But HDL-cholesterol showed borderline values. Horri and Va-
kil i32 stated that serum TG and cholesterol levels were signif-
icantly higher in obese children and adolescents. Also, there is
signiﬁcant positive correlation between BMI percentiles and
serum TG, total and LDL-cholesterol. In addition, HDL-cho-
lesterol was signiﬁcantly lower in the obese children than
control.
Obesity predisposes to hypertension because of concomi-
tant metabolic and hemodynamic abnormalities leading to
inadequate lowering of systemic resistance and, therefore, to
more severe cardiovascular burden.33 Many of cardiovascular
complications related to obesity may begin in childhood and
adolescence. Furthermore, it has been shown that obesity is
associated with the development of early myocardial and cor-
onary artery changes in children.17
When complications of obesity are already established, as
coronary artery disease, positive correlations are observed be-
tween markers of lipid peroxidation, total cholesterol and TG
and negative ones are noted with high-density lipoproteins
(HDL).34
As regards echocardiographic evaluation, there was no sig-
niﬁcant difference between the two studied groups as regards
the LVEF (%) and the LVFS (%). Hence all children had nor-
mal LV systolic function. These results were in agreement with
those of Mehta et al.,12 Di Salvo et al.35 and Khositseth et al.17
On the other hand, Chinali et al.11 found a signiﬁcantly
lower ejection fraction in obese adolescents as compared to
non-obese group. Moreover, Alpert36 found that obese sub-
jects demonstrated evidence of diminished myocardial func-
tion, which was directly related to the severity and duration
of their adiposity. The hearts of these subjects were character-
ized by reduced LVEF; which were often independent of ef-
fects of hypertension or coexistent coronary artery disease.
Gutin et al.37 reported that among children aged 7–
13 years, percent body fat correlated negatively with lower
mid-wall ventricular shortening fraction. Mensah et al.38
found a signiﬁcant negative association between LVSF and
central adiposity in a group of 15-year old subjects.
The explanation for these differences in depression of myo-
cardial function is related to both severity and duration of ex-
cess adiposity, myocardial fatigue due to chronic volume
overwork, and metabolic derangements associated with obes-
ity such as insulin resistance which modify myocardial sub-
strate utilization, increase in myocardial fatty acid oxidation
and oxygen consumption and leading to myocardial
dysfunction.39,40
As regards the LV dimensions in our study, there was sig-
niﬁcant increase in the LVEDD, predicted LVEDD and %
LVEDD in obese than controls, indicating left ventricularenlargement. Positive cross-sectional associations between
body fat content and cardiac chamber dimensions have been
evident among cohorts of obese subjects41 as well as in studies
in the general pediatric population.11,37,38,42,43
Chinali et al.11 reported that cardiac enlargement in obesity
is caused by response to a chronically increased hemodynamic
load. Moreover, Rowland40 found a correlation between body
mass index and left ventricular end diastolic dimension in a
group of early adolescent females.
An obese child is characterized by an expanded circulatory
system reﬂecting somatic growth, increased plasma volume,
hypertrophy of myocardial ﬁbers, and cardiac chamber
enlargement.40
LV-mass has been established as an independent risk factor
for cardiovascular morbidity and mortality.44,45 Since LV-
mass is affected by body size, a variety of factors have been
proposed for indexing LV-mass.44
In our study, the standard echocardiographic evaluation of
obese, non-hypertensive children showed signiﬁcant increase in
the left ventricular mass (LVM) and left ventricular mass index
(LVMI) as compared to the control group, which indicated left
ventricular hypertrophy (LVH). These results were in agree-
ment with those of Chinali et al.11 Khositseth et al.17 and Di
Salvo et al.35
Attention has been focused on the role of the anabolic ef-
fects of hyperinsulinemia on myocardial hypertrophy, a reﬂec-
tion of the insulin resistance commonly observed in obese
individuals.45–48
The American Heart Association (AHA) has stressed the
importance of obesity as a modiﬁable, independent risk fac-
tor for coronary artery disease, ventricular dysfunction, con-
gestive heart failure, and cardiac arrhythmias.49 Similarly,
adolescent obesity is strongly related to adult obesity and
may progress to type 2 diabetes and/or hypertension.50 Adult
obesity has been shown to be associated with increased left
ventricular mass (LVM) and both systolic and diastolic dys-
function,36 all are important predictors of adverse cardiovas-
cular outcome and identiﬁcation of a pre-clinical
cardiovascular disease.51
Chinali et al.11 stated that even in adolescents, the severity
of obesity parallels early cardiac changes, including high prev-
alence of LVH and increased hemodynamic load. Moreover,
Friberg et al.52 reported that the increased LVM occurs to sus-
tain the increased cardiac workload.
At higher stages of obesity, increase in LVM is not depend-
ing only on hemodynamic load but also on non-hemodynamic
factors; neuro-hormonal effects of clustered metabolic factors
inﬂuencing LV growth,11 high blood pressure and dietary so-
dium intake.53 However, LV dilatation and hypertrophy are
independent of the level of blood pressure.54
The LMPI indicates both systolic and diastolic myocardial
functions. LMPI signiﬁcantly increased in obese as compared
to the control group. This was in agreement with Khositseth
et al.17 who reported that despite normal LV dimensions and
systolic function in obese children of their study, the abnormal
LMPI may be one of the sensitive indicators for the early
detection of LV global dysfunction in those children.
So, LMPI may be an indicator for early recognition of the
cardiac related complications of obesity in children. This sim-
ple reproducible index may be useful to identify the high-risk
patients requiring an aggressive weight-control/reduction
program.17
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Complete evaluation of cardiac function in obese children
should include echocardiography along with LMPI (as a useful
marker for early detection of LV global dysfunction), in com-
bination with measurement of lipid proﬁle. Also it helps to
identify the high-risk obese children requiring weight-control/
reduction programs to encourage healthy life styles and reduce
morbidity and mortality.
It is recommended in the future studies, to clarify the effects
of obesity on cardiac function and lipid proﬁle, even in infants
and young children.References
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